Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
429.9 USD | +1.69% | +6.81% | +5.66% |
11:53am | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
10/05 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.66% | 111B | |
+11.23% | 105B | |
-2.85% | 21.93B | |
-12.15% | 22.34B | |
-5.29% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B | |
+288.77% | 7.98B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated, Q1 2019 Earnings Call, Apr 30, 2019